The c-Jun-N-Terminal Kinase is Involved in the Neurotoxic Effect of Azaspiracid-1
Authors:
- Carmen ValeCVCarmen Vale
- Belén Gómez-LimiaBGBelén Gómez-Limia
- K.C. NicolaouKNK.C. Nicolaou
- Michael O. FrederickMFMichael O. Frederick
- Mercedes R. VieytesMVMercedes R. Vieytes
- Luis M. BotanaLuis M. Botana
- 1 October 2007
- journal article
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 20 (6) , 957-966
Abstract
Azaspiracids (AZAs) are marine phycotoxins with an unknown mechanism of action, recently implicated in human intoxications. The predominant analog in nature, AZA-1 targets several organs in vivo, including the central nervous system and exhibits high neurotoxicity in vitro. We used pharmacological tools to inhibit the cytotoxic effect of the toxin in primary cultured neurons. Immunocytochemical techniques in combination with confocal microscopy were employed to examine the cellular mechanisms involved in the neurotoxic effect of AZA-1. Several targets for azaspiracid-induced neurotoxicity, specifically the cAMP pathway, or protein kinase C and phosphatidylinositol 3-kinase activation were excluded. Interestingly, the specific c-Jun-N-terminal protein kinase (JNK) inhibitor SP 600125 protected cultured neurons against AZA-induced cytotoxicity. Immunocytochemistry experiments showed that AZA-1 increased the amount of phosphorylated JNK and caused nuclear translocation of the active protein that was prevented by SP 600125. Our data constitute the relationship between azaspiracid-induced cytotoxicity and specific modifications in cellular transduction signals, specifically we found that JNK activation is associated with the cytotoxic effect of the toxin. These results should provide the basis to identify the mechanism of action of this group of toxins.Keywords
This publication has 40 references indexed in Scilit:
- Total Synthesis and Structural Elucidation of Azaspiracid-1. Final Assignment and Total Synthesis of the Correct Structure of Azaspiracid-1Journal of the American Chemical Society, 2006
- Total Synthesis of the Proposed Azaspiracid‐1 Structure, Part 1: Construction of the Enantiomerically Pure C1–C20, C21–C27, and C28–C40 FragmentsAngewandte Chemie International Edition, 2003
- The first identification of azaspiracids in shellfish from France and SpainToxicon, 2003
- Ubiquitous ‘benign’ alga emerges as the cause of shellfish contamination responsible for the human toxic syndrome, azaspiracid poisoningToxicon, 2003
- First evidence of an extensive northern European distribution of azaspiracid poisoning (AZP) toxins in shellfishToxicon, 2002
- Chronic effects in mice caused by oral administration of sublethal doses of azaspiracid, a new marine toxin isolated from musselsToxicon, 2002
- Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in IrelandToxicon, 2000
- A sensitive and specific determination method for azaspiracids by liquid chromatography mass spectrometryNatural Toxins, 1999
- Two analogs of azaspiracid isolated from mussels, Mytilus edulis, involved in human intoxication in IrelandNatural Toxins, 1999
- Azaspiracid, a New Marine Toxin Having Unique Spiro Ring Assemblies, Isolated from Irish Mussels, Mytilus edulisJournal of the American Chemical Society, 1998